# CycleReady Phase 5 UAT Signoff Sheet

Record approvals once all scripts are executed, documented, and blockers addressed. Include signatures for the Clinician and Reviewer personas, along with the QA lead approving the release.

## Release Details
- **Release Name / Candidate:** Phase 5 UAT Release Candidate
- **Environment:** CycleReady QA (`uat.cycleready.local`) or equivalent preview build
- **Date(s) of Testing:** e.g., March 9–13, 2026
- **Tester Lead:** qa-lead@cycleready.com
- **Business Owner:** product-owner@cycleready.com

## Signoff Table
| Persona / Role | Tester Name | Tests Covered | Status | Signature & Date |
| --- | --- | --- | --- | --- |
| Clinician — Credithound (regular submitter) |  | UAT-01, UAT-02, UAT-06 | ☐ Pass ☐ Fail ☐ Blocked |  |
| Clinician — Busy Documenter (needs reminders) |  | UAT-03, UAT-04 | ☐ Pass ☐ Fail ☐ Blocked |  |
| Reviewer / Staff Auditor |  | UAT-05 | ☐ Pass ☐ Fail ☐ Blocked |  |
| QA Lead / Test Coordinator |  | All scripts reviewed | ☐ Approve ☐ Defer |  |

## Signoff Criteria
1. All UAT scripts are executed and documented in `docs/uat-results.md`.
2. Any defects are logged in GitHub with the `phase-5-uat` label and referenced in the results log.
3. Blocking issues are resolved or deferred with stakeholder agreement before the QA Lead signs off.
4. Business Owner and Product Stakeholder review summary observations and agree to release.

## Notes / Exceptions
- Document any deviations (e.g., test environment instability, loaded data variances, additional manual steps) that impacted execution. Include mitigation plans or follow-up owners.
